Ceramide and cholesterol: Possible connections between normal aging of the brain and Alzheimer's disease. Just hypotheses or molecular pathways to be identified?

Alzheimer's and Dementia

Volumn 1, Issue 1, 2005, Pages 43-50

  Costantini, Claudio ^a   Kolasani, Rekha M K ^a   Puglielli, Luigi ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Aging; Alzheimer's disease; Ceramide; Cholestrol

Indexed keywords

ABC TRANSPORTER A1; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANTERIOR PHARYNX DEFECTIVE 1 PROTEIN; BETA SECRETASE; CERAMIDE; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; GAMMA SECRETASE; NICASTRIN; PRESENILIN 1; PRESENILIN 2; SPHINGOMYELIN PHOSPHODIESTERASE;

AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN FUNCTION; CHOLESTEROL METABOLISM; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; HYPOTHESIS; INCIDENCE; LIFESPAN; MEDICAL RESEARCH; MOLECULAR MECHANICS; NEUROPATHOLOGY; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SYNAPTOGENESIS;

EID: 33644811578     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2005.06.004     Document Type: Article

References (55)

1. L. Bertram R.E. Tanzi Alzheimer's disease: One disorder, too many genes? Hum Mol Genet 13 2004 R131-R141
2. E.H. Corder A.M. Saunders W.J. Strittmatter D.E. Schmechel P.C. Gaskell G.W. Small et. al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 1993 921-923
3. R.E. Tanzi L. Bertram New frontiers in Alzheimer's disease genetics Neuron 32 2001 181-184
4. B. De Strooper W. Annaert Proteolytic processing and cell biological functions of the amyloid precursor protein J Cell Sci 113 2000 1857-1870
5. L. Puglielli R.E. Tanzi D.M. Kovacs Alzheimer's disease: The cholesterol connection Nat Neurosci 6 2003 345-351
6. D.J. Selkoe Cell biology of protein misfolding the examples of Alzheimer's and Parkinson's diseases Nat Cell Biol 6 2004 1054-1061
7. D.J. Selkoe Translating cell biology into therapeutic advances in Alzheimer's disease Nature 399 1999 A23-A31
8. R. Vassar B.D. Bennett S. Babu-Khan S. Kahn E.A. Mendiaz P. Denis et. al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE Science 286 1999 735-741
9. I. Hussain D. Powell D.R. Howlett D.G. Tew T. Meek C. Chapman et. al. Identification of a novel aspartic protease (Asp 2) as beta-secretase Mol Cell Neurosci 14 1999 419-427
10. R. Yan M.J. Bienkowski M.E. Shuck H. Miao M.C. Tory A.M. Pauley et. al. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity Nature 402 1999 533-537
11. S. Sinha J.P. Anderson R. Barbour G.S. Basi R. Caccavello D. Davis et. al. Purification and cloning of amyloid precursor protein beta-secretase from human brain Nature 402 1999 537-540
12. G. Yu M. Nishimura S. Arawaka D. Levitan L. Zhang A. Tandon et. al. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing Nature 407 2000 48-54
13. R. Francis G. McGrath J. Zhang D.A. Ruddy M. Sym J. Apfeld et. al. aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation Dev Cell 3 2002 85-97
14. C. Goutte M. Tsunozaki V.A. Hale J.R. Priess APH-1 is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryos Proc Natl Acad Sci U S A 99 2002 775-779
15. B. De Strooper Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex Neuron 38 2003 9-12
16. J.C. Morris Is Alzheimer's disease inevitable with age?: Lessons from clinicopathologic studies of healthy aging and very mild Alzheimer's disease J Clin Invest 104 1999 1171-1173
17. L. Puglielli B.C. Ellis A.J. Saunders D.M. Kovacs Ceramide stabilizes beta-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid beta-peptide biogenesis J Biol Chem 278 2003 19777-19783
18. M.E. Venable J.Y. Lee M.J. Smyth A. Bielawska L.M. Obeid Role of ceramide in cellular senescence J Biol Chem 270 1995 30701-30708
19. M.E. Venable L.M. Obeid Phospholipase D in cellular senescence Biochem Biophys Acta 1439 1999 291-298
20. F. Irie Y. Hirabayashi Application of exogenous ceramide to cultured rat spinal motoneurons promotes survival or death by regulation of apoptosis depending on its concentrations J Neurosci Res 54 1998 475-485
21. T. Ariga W.D. Jarvis R.K. Yu Role of sphingolipid-mediated cell death in neurodegenerative diseases J Lipid Res 39 1998 1-16
22. S.A. Lightle J.I. Oakley M.N. Nikolova-Karakashian Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging Mech Ageing Dev 120 2000 111-125
23. R.E. Mouton M.E. Venable Ceramide induces expression of the senescence histochemical marker, beta-galactosidase, in human fibroblasts Mech Ageing Dev 113 2000 169-181
24. C.J. Miller G.H. Stein Human diploid fibroblasts that undergo a senescent-like differentiation have elevated ceramide and diacylglycerol J Gerontol A Biol Sci Med Sci 56 2001 B8-B19
25. R.G. Cutler J. Kelly K. Storie W.A. Pedersen A. Tammara K. Hatanpaa et. al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease Proc Natl Acad Sci U S A 101 2004 2070-2075
26. X. Han D MH D.W. McKeel Jr J. Kelley J.C. Morris Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease potential role in disease pathogenesis J Neurochem 82 2002 809-818
27. E.P. de Chaves M. Bussiere B. MacInnis D.E. Vance R.B. Campenot J.E. Vance Ceramide inhibits axonal growth and nerve growth factor uptake without compromising the viability of sympathetic neurons J Biol Chem 276 2001 36207-36214
28. M.F. DeFreitas P.S. McQuillen C.J. Shatz A novel p75NTR signaling pathway promotes survival, not death, of immunopurified neocortical subplate neurons J Neurosci 21 2001 5121-5129
29. N.P. D'Mello A.M. Childress D.S. Franklin S.P. Kale C. Pinswasdi S.M. Jazwinski Cloning and characterization of LAG1, a longevity-assurance gene in yeast J Biol Chem 269 1994 15451-15459
30. S. Schorling B. Vallee W.P. Barz H. Riezman D. Oesterhelt Lag1p and Lac1p are essential for the Acyl-CoA-dependent ceramide synthase reaction in Saccharomyces cerevisae Mol Biol Cell 12 2001 3417-3427
31. I. Guillas P.A. Kirchman R. Chuard M. Pfefferli J.C. Jiang S.M. Jazwinski et. al. C26-CoA-dependent ceramide synthesis of Saccharomyces cerevisiae is operated by Lag1p and Lac1p Embo J 20 2001 2655-2665
32. J.C. Jiang P.A. Kirchman M. Zagulski J. Hunt S.M. Jazwinski Homologs of the yeast longevity gene LAG1 in Caenorhabditis elegans and human Genome Res 8 1998 1259-1272
33. K. Venkataraman A.H. Futerman Ceramide as a second messenger sticky solutions to sticky problems Trends Cell Biol 10 2000 408-412
34. K. Sandhoff G. van Echten Metabolism of gangliosides topology, pathobiochemistry, and sphingolipid activator proteins D. Hoekstra Current topics in membranes. Cell lipids. Vol 40 1994 Academic Press San Diego 75-91
35. S. Tomiuk K. Hofmann M. Nix M. Zumbansen W. Stoffel Cloned mammalian neutral sphingomyelinase: Functions in sphingolipid signaling? Proc Natl Acad Sci U S A 95 1998 3638-3643
36. K. Hofmann S. Tomiuk G. Wolff W. Stoffel Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase Proc Natl Acad Sci U S A 97 2000 5895-5900
37. H. Sawai N. Domae N. Nagan Y.A. Hannun Function of the cloned putative neutral sphingomyelinase as lyso-platelet activating factor-phospholipase C J Biol Chem 274 1999 38131-38139
38. M. Zumbansen W. Stoffel Neutral sphingomyelinase 1 deficiency in the mouse causes no lipid storage disease Mol Cell Biol 22 2002 3633-3638
39. N. Marchesini C. Luberto Y.A. Hannun Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism J Biol Chem 278 2003 13775-13783
40. A.B. Brann R. Scott Y. Neuberger D. Abulafia S. Boldin M. Fainzilber et. al. Ceramide signaling downstream of the p75 neurotrophin receptor mediates the effects of nerve growth factor on outgrowth of cultured hippocampal neurons J Neurosci 19 1999 8199-8206
41. A. Ito K. Horigome Ceramide prevents neuronal programmed cell death induced by nerve growth factor deprivation J Neurochem 65 1995 463-466
42. D.H. Mauch K. Nagler S. Schumacher C. Goritz E.C. Muller A. Otto et. al. CNS synaptogenesis promoted by glia-derived cholesterol Science 294 2001 1354-1357
43. R. Ehehalt P. Keller C. Haass C. Thiele K. Simons Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts J Cell Biol 160 2003 113-123
44. L. Puglielli G. Konopka E. Pack-Chung L.A. Ingano O. Berezovska B.T. Hyman et. al. Acyl-coenzyme: A cholesterol acyltransferase modulates the generation of the amyloid beta-peptide Nat Cell Biol 3 2001 905-912
45. B. Hutter-Paier H.J. Huttunen L. Puglielli C.B. Eckman D.Y. Kim A. Hofmeister et. al. The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease Neuron 44 2004 227-238
46. Q. Zhang E.T. Powers J. Nieva M.E. Huff M.A. Dendle J. Bieschke et. al. Metabolite-initiated protein misfolding may trigger Alzheimer's disease Proc Natl Acad Sci U S A 101 2004 4752-4757
47. C. Opazo X. Huang R.A. Cherny R.D. Moir A.E. Roher A.R. White et. al. Metalloenzyme-like activity of Alzheimer's disease beta-amyloid Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2) J Biol Chem 277 2002 40302-40308
48. T.J. Nelson D.L. Alkon Oxidation of cholesterol by amyloid precursor protein and beta-amyloid peptide J Biol Chem 280 2005 7377-7387
49. J.A. Tschape C. Hammerschmied M. Muhlig-Versen K. Athenstaedt G. Daum D. Kretzschmar The neurodegeneration mutant lochrig interferes with cholesterol homeostasis and Appl processing Embo J 21 2002 6367-6376
50. S. Pedrini T.L. Carter G. Prendergast S. Petanceska M.E. Ehrlich S. Gandy Modulation of Statin-Activated Shedding of Alzheimer APP Ectodomain by ROCK PLoS Med 2 2005 e18
51. S.L. Cole A. Grudzien I.O. Manhart B.L. Kelly H. Oakley R. Vassar Statins cause intracellular accumulation of APP, beta-secretase cleaved fragments, and Abeta via an isoprenoid-dependent mechanism J Biol Chem 280 2005 18755-18770
52. G.W. Rebeck Cholesterol efflux as a critical component of Alzheimer's disease pathogenesis J Mol Neurosci 23 2004 219-224
53. J.M. Dietschy S.D. Turley Cholesterol metabolism in the brain Curr Opin Lipidol 12 2001 105-112
54. T.S. Worgall R.A. Juliano T. Seo R.J. Deckelbaum Ceramide synthesis correlates with the posttranscriptional regulation of the sterol-regulatory element-binding protein Arterioscler Thromb Vasc Biol 24 2004 943-948
55. A.J. Brown E.L. Mander I.C. Gelissen L. Kritharides R.T. Dean W. Jessup Cholesterol and oxysterol metabolism and subcellular distribution in macrophage foam cells Accumulation of oxidized esters in lysosomes J Lipid Res 41 2000 226-237